The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $18.32 in the prior trading day, Syndax Pharmaceuticals Inc (NASDAQ: SNDX) closed at $17.99, down -1.80%. In other words, the price has decreased by -$1.80 from its previous closing price. On the day, 0.77 million shares were traded. SNDX stock price reached its highest trading level at $18.5878 during the session, while it also had its lowest trading level at $17.95.
Ratios:
Our goal is to gain a better understanding of SNDX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.50 and its Current Ratio is at 10.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on June 28, 2024, initiated with a Buy rating and assigned the stock a target price of $37.
On January 31, 2024, Scotiabank Downgraded its rating to Sector Perform which previously was Sector Outperform and also lowered its target price recommendation from $36 to $23.
On December 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $45.Mizuho initiated its Buy rating on December 22, 2023, with a $45 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 14 ’24 when Goldan Keith A. bought 1,250 shares for $20.03 per share. The transaction valued at 25,037 led to the insider holds 52,623 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNDX now has a Market Capitalization of 1530884224 and an Enterprise Value of 1127828224. For the stock, the TTM Price-to-Sale (P/S) ratio is 437.41 while its Price-to-Book (P/B) ratio in mrq is 3.52. Its current Enterprise Value per Revenue stands at 322.237 whereas that against EBITDA is -3.916.
Stock Price History:
Over the past 52 weeks, SNDX has reached a high of $25.34, while it has fallen to a 52-week low of $11.22. The 50-Day Moving Average of the stock is -15.29%, while the 200-Day Moving Average is calculated to be -14.82%.
Shares Statistics:
The stock has traded on average 1.06M shares per day over the past 3-months and 1127930 shares per day over the last 10 days, according to various share statistics. A total of 84.83M shares are outstanding, with a floating share count of 79.45M. Insiders hold about 6.64% of the company’s shares, while institutions hold 97.07% stake in the company. Shares short for SNDX as of 1723680000 were 9434441 with a Short Ratio of 8.97, compared to 1721001600 on 8522704. Therefore, it implies a Short% of Shares Outstanding of 9434441 and a Short% of Float of 11.18.
